Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; powder and solid systems; clean utility equipment and systems; clean room, automation control, and monitor systems; and freeze-dryer, sterile filling, and visual inspection equipment. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers design, quality risk control, consulting, research and development support, process engineering, digitalization construction, after-sale, on-site, upgrading, relocation, and asset management services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides assembly and pre-assembly services. The company was founded in 1991 and is headquartered in Shanghai, China.

Austar Lifesciences Limited

AUSTAR is a technology-based pharmaceutical engineering solution provider with a deep understanding of industry regulations and processes. The company integrates global high-quality resources to help clients improve process and operational effectiveness.

Metric
Company Name	Austar Lifesciences Limited
Symbol	6.12K
MSH ID	HK:COM:AUSTAR
Market	STOCKS
Sector	Healthcare
Industry	Medical - Devices
Country	CN
Stage
Employee Count	1.61K
Website	austar.com.hk
LinkedIn
Founders

Metric
Market Cap	40.19M
Enterprise Value
Monthly Web Traffic	950
Web Traffic Growth	-0.25
Valuation
Raised Capital

Metric
Revenue	242.59M
Revenue (LTM)
Revenue (NTM)
Gross Profit	46.22M
EBITDA	-2.83M
Operating Income	-4.99M
Net Income	-4.48M
EPS	-0.01
Diluted EPS	-0.01
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.21
Operating Profit Margin	0.01
EBITDA Margin	-0.01
Net Profit Margin	0.00
Return on Equity	0.00
Return on Assets	0.00
Return on Capital Employed	0.01

6118

HK:COM:AUSTAR

AUSTAR

Last Close

0.61

25/11 06:12

Market Cap

312.68M

Beta: -

Volume Today

264K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	11.83
P/B Ratio	0.89
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.52
EV Multiple	3.78

Metric
Days Sales Outstanding
Days Payables Outstanding	88.09
Days Inventory Outstanding	108.63
Operating Cycle	485.15
Cash Conversion Cycle	303.80
Asset Turnover	0.97

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt	0.05
Operating Cash Flow/Sales	0.01
Free Cash Flow Yield	-0.22

Metric
Cash & Equivalents	22.53M
Accounts Receivable
Inventory	33.45M
Goodwill
Debt to Capitalization	0.39
Debt to Assets	0.14
Current Ratio	1.32
Quick Ratio	1.13

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.03
SG&A to Revenue	0.06